Showing results (1441-1450 of 1,523) with videos related to

Sort By:
Pageof 153
Molecular Oncology|April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapyHai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
The Lancet. Oncology|December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 studyYi-Long Wu, Yu Yao, Jin-Ji Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor CellsBen-Yuan Jiang, Yang-Si Li, Wei-Bang Guo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study GroupSamantha J Mayo, Maryam Lustberg, Haryana M Dhillon, et al.
Signal Transduction and Targeted Therapy|February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trialWen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.
Journal of Translational Medicine|April 2, 2024
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancerWei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2023
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 TrialByoung Chul Cho, Jong Seok Lee, Yi-Long Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerDavid R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, et al.
Clinical Lung Cancer|September 23, 2022
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic ConsiderationsMyung-Ju Ahn, Marvin Jonne L Mendoza, Nick Pavlakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, et al.
Pageof 153